A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy

NCT00489151 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

70

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: adefovir dipivoxil
DRUG: lamivudine

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]